74 related articles for article (PubMed ID: 9357514)
21. 5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structure-affinity relationships for h5-HT1B and h5-HT1D receptors.
Barf T; Wikström H; Pauwels PJ; Palmier C; Tardif S; Lundmark M; Sundell S
Bioorg Med Chem; 1998 Sep; 6(9):1469-79. PubMed ID: 9801818
[TBL] [Abstract][Full Text] [Related]
22. Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists.
De Ponti F; Crema F; Moro E; Nardelli G; Frigo G; Crema A
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G96-104. PubMed ID: 12646419
[TBL] [Abstract][Full Text] [Related]
23. 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
Russell MG; Matassa VG; Pengilley RR; van Niel MB; Sohal B; Watt AP; Hitzel L; Beer MS; Stanton JA; Broughton HB; Castro JL
J Med Chem; 1999 Dec; 42(24):4981-5001. PubMed ID: 10585208
[TBL] [Abstract][Full Text] [Related]
24. N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.
Xu YC; Schaus JM; Walker C; Krushinski J; Adham N; Zgombick JM; Liang SX; Kohlman DT; Audia JE
J Med Chem; 1999 Feb; 42(3):526-31. PubMed ID: 9986723
[TBL] [Abstract][Full Text] [Related]
25. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
26. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
[TBL] [Abstract][Full Text] [Related]
27. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
Heightman TD; Gaster LM; Pardoe SL; Pilleux JP; Hadley MS; Middlemiss DN; Price GW; Roberts C; Scott CM; Watson JM; Gordon LJ; Holland VA; Powles J; Riley GJ; Stean TO; Trail BK; Upton N; Austin NE; Ayrton AD; Coleman T; Cutler L
Bioorg Med Chem Lett; 2005 Oct; 15(19):4370-4. PubMed ID: 16039851
[TBL] [Abstract][Full Text] [Related]
28. Eletriptan Pfizer.
Strijbos PJ; Parsons AA; Fugelli A
Curr Opin Investig Drugs; 2002 Sep; 3(9):1359-68. PubMed ID: 12498013
[TBL] [Abstract][Full Text] [Related]
29. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands.
Prisinzano T; Law H; Dukat M; Slassi A; MaClean N; Demchyshyn L; Glennon RA
Bioorg Med Chem; 2001 Mar; 9(3):613-9. PubMed ID: 11310595
[TBL] [Abstract][Full Text] [Related]
30. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
Hillegaart V; Ahlenius S
Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
[TBL] [Abstract][Full Text] [Related]
31. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT₇ receptor antagonists.
Zajdel P; Kurczab R; Grychowska K; Satała G; Pawłowski M; Bojarski AJ
Eur J Med Chem; 2012 Oct; 56():348-60. PubMed ID: 22926225
[TBL] [Abstract][Full Text] [Related]
32. Localisation of mRNA for h5-HT1B and h5-HT1D receptors in human dorsal raphe.
Bidmon HJ; Schleicher A; Wicke K; Gross G; Zilles K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):364-8. PubMed ID: 11284452
[TBL] [Abstract][Full Text] [Related]
33. 2,7-diazabicyclo[3.3.0]octanes as novel h5-HT receptor agonists.
Russell MG; Beer MS; Stanton JA; Sohal B; Mortishire-Smith RJ; Castro JL
Bioorg Med Chem Lett; 1999 Sep; 9(17):2491-6. PubMed ID: 10498195
[TBL] [Abstract][Full Text] [Related]
34. 5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity.
Macor JE; Blank DH; Fox CB; Lebel LA; Newman ME; Post RJ; Ryan K; Schmidt AW; Schulz DW; Koe BK
J Med Chem; 1994 Aug; 37(16):2509-12. PubMed ID: 8057297
[No Abstract] [Full Text] [Related]
35. A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties.
Laban U; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE
Bioorg Med Chem Lett; 2001 Mar; 11(6):793-5. PubMed ID: 11277522
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin.
Macor JE; Blake J; Fox CB; Johnson C; Koe BK; Lebel LA; Morrone JM; Ryan K; Schmidt AW; Schulz DW
J Med Chem; 1992 Nov; 35(23):4503-5. PubMed ID: 1447752
[No Abstract] [Full Text] [Related]
37. (R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands.
Egle I; MacLean N; Demchyshyn L; Edwards L; Slassi A; Tehim A
Bioorg Med Chem Lett; 2003 Oct; 13(20):3419-21. PubMed ID: 14505640
[TBL] [Abstract][Full Text] [Related]
38. Sodium dependency of constitutive activity at 5-HT1D alpha/1D beta receptors.
Gray DW; Giles H; Barrett V; Martin GR
Ann N Y Acad Sci; 1997 May; 812():236-9. PubMed ID: 9186755
[No Abstract] [Full Text] [Related]
39. Synthesis and analgesic activity of some side-chain modified anpirtoline derivatives.
Rádl S; Hezky P; Proska J; Hejnová L; Krejcí I
Arch Pharm (Weinheim); 2000 May; 333(5):107-12. PubMed ID: 10863793
[TBL] [Abstract][Full Text] [Related]
40. Oral oxytocin antagonists.
Borthwick AD
J Med Chem; 2010 Sep; 53(18):6525-38. PubMed ID: 20550119
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
